Relationship between plasma adiponectin levels and metabolic risk profiles in Taiwanese children

Obesity Research

Volumn 13, Issue 11, 2005, Pages 2014-2020

  Chu, Nain Feng ^a,b   Shen, Muh Han ^c   Wu, Der Min ^c   Lai, Chen Ju ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c NONE

Author keywords

Adiponectin; Children; Insulin resistance; Metabolic risk

Indexed keywords

ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BLOOD; BLOOD PRESSURE; BODY MASS; CHILD; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; INSULIN RESISTANCE; MALE; MULTIVARIATE ANALYSIS; OBESITY; REGRESSION ANALYSIS; RISK FACTOR; TAIWAN;

ADIPONECTIN; ADOLESCENT; BLOOD PRESSURE; BODY MASS INDEX; CHILD; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LEPTIN; MALE; MULTIVARIATE ANALYSIS; OVERWEIGHT; REGRESSION ANALYSIS; RISK FACTORS; TAIWAN; TRIGLYCERIDES;

EID: 33644823599     PISSN: 10717323     EISSN: None     Source Type: Journal    
DOI: 10.1038/oby.2005.247     Document Type: Article

References (53)

1. Garrow JS. Health Implications of Obesity: Obesity and Related Diseases. London, United Kingdom: Churchill Livingstone; 1988, pp. 1-16.
2. Gidding SS. A perspective on obesity. Am J Med Sci. 1995; 310(Suppl 1):S68-71.
3. Bray G A. Health hazards of obesity. Endocrinol Metab Clin North Am. 1996;25:907-19.
4. Gidding SS, Leibel RL, Daniel S, Rosenbaum M, van Horn L, Marx GR. Understanding obesity in youth. Circulation. 1996:94:3383-7.
5. Dietz WH Jr. Obesity in infants, children, and adolescents in the United States: I. Identification, natural history, and aftereffects. Nutr Res. 1981;1:117-37.
6. Aristimuno GG, Foster TA, Voors AW, Srinivasan SR, Berenson GS. Influence of persistent obesity in children on cardiovascular risk factors: the Bogalusa Heart Study. Circulation. 1984;69:895-904.
7. Smoak CG, Burke GL, Webber LS, Harsha DW, Srinivasan SR, Berenson GS. Relation of obesity to clustering of cardiovascular disease risk factors in children and young adults: The Bogalusa Heart Study. Am J Epidemiol. 1987;125: 364-72.
8. Lauer RM, Clarke WR. Childhood risk factors for high adult blood pressure: the Muscatine Study. Pediatrics. 1989;84: 633-41.
9. Gidding SS, Bao W, Srinivasan SR, Berenson GS. Effects of secular trends in obesity on coronary risk factors in children: the Bogalusa Heart Study. J Pediatr. 1995;127: 868-74.
10. Dietz WH. Childhood weight affects adult morbidity and mortality. J Nutr. 1998;128(Suppl 2):411-4S.
11. Guillaume M, Lapidus L, Björntorp P, Lambert A. Physical activity, obesity, and cardiovascular risk factors in children: The Belgian Luxembourg Child Study II. Obes Res. 1997:5:549-56.
12. Lauer RM, Lee J, Clarke WR. Factors affecting the relationship between childhood and adult cholesterol levels: the Muscatine Study. Pediatrics. 1988;82:309-18.
13. Falkner F. Obesity and cardiovascular disease risk factors in prepubescent and pubescent black and white females. Crit Rev Food Sci Nutr. 1993;33:397-402.
14. Kannel WB, Gordon T, Castelli WP. Obesity, lipids, and glucose intolerance: The Framingham Study. Am J Clin Nutr. 1979;32:1238-45.
15. Kahn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000;106:473-81.
16. Everson SA, Goldberg DE, Helmrich SP, et al. Weight gain and the risk of developing insulin resistance syndrome. Diabetes Care. 1998:21:1637-43.
17. Caro JF. Insulin resistance in obese and non-obese men. J Clin Endocriol Metab. 1991;73:691-5.
18. Flack JM, Sowers JR. Epidemiologic and clinical aspects of insulin resistance and hyperinsulinemia. Am J Med. 1991; 91(Suppl 1A):11-21S.
19. Reaven GM, Laws A. Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease. Diabetolgia. 1994:37:948-52.
20. Raitakari OT, Porkka KVK, Ronnemaa T, et al. The role of insulin in clustering of serum lipids and blood pressure in children and adolescent. Diabetologia. 1995;38:1042-50.
21. Bao W, Srinivasan SR, Wattigney WA, Berenson GS. Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to young adulthood: The Bogalusa Heart Study. Arch Int Med. 1994;154:1842-7.
22. Bao W, Srinivasan SR, Berenson GS. Persistent elevation of plasma insulin levels is associated with increased cardiovascular risk in children and young adults: The Bogalusa Heart Study. Circulation. 1996;93:54-9.
23. Arslanian S, Suprasongsin C. Insulin sensitivity, lipids, and body composition in childhood: is "syndrome X" present? J Clin Endocrinol Metab. 1996:81:1058-62.
24. Srinivasan SR, Myers L, Berenson GS. Temporal association between obesity and hyperinsulinemia in children, adolescents, and young adults: the Bogalusa Heart Study. Metab Clin Exp. 1999:48:928-34.
25. Mohamed-All V, Pinkney JH, Coppack SW. Adipose tissueas an endocrine and paracrine organ. Int J Obes. 1998;22: 1145-58.
26. Wiecek A, Kokot F, Cudek J, Adamczak M. The adipose tissue: a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant. 2002;17:191-5.
27. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001;60:329-39.
28. Sethi JK, Hotamisligil GS. The role of TNF alpha in adipocyte metabolism. Semin Cell Develop Biol. 1999;10:19-29.
29. Schwartz MW, Prigeon RL, Kahn SE, et al. Evidence that plasma leptin and insulin levels are associated with body adiposity via different mechanisms, Diabetes Care. 1997:20: 1476-81.
30. Yokota T, Oritani K, Takahashi I, et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96:1723-32.
31. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K. cDNA cloning and expression of a novel adipose specific collagen-like factor. apM1 (adipose most abundant gene transcript 1). Biochem Biophy Ren Commun. 1996:221:286-98.
32. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin. in obesity. Biochem Biophy Res Commun. 1999:257:79-83.
33. Zoccali C, Mallamaci F, Tripepi G, et al. Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol. 2002: 13:134-41.
34. Matsuzawa Y, Funahashi T, Nakamura T. Molecular mechanism of metabolic syndrome X: Contribution of adipocytokine: adipocyte-derived bioactive substances. Ann New York Acad Sci. 1999;892:146-54.
35. Comuzzie AG, Funahashi T, Sonnenberg G, et al. The genetic basis of plasma variation in adiponectin, a global endophenotype for obesity and the metabolic syndrome. J Clin Endocrinol Metabol. 2001;86:4321-5.
36. MacDougald OA, Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrinol Metabol. 2002:13:5-11.
37. Stefan N, Bunt JC, Salbe AD, et al. Plasma adiponectin concentrations in children: relationship with obesity and insulinemia. J Clin Endocrinol Metab. 2002:87:4652-6.
38. Nemet D, Wang P, Funahashi T, et al. Adipocytokines. body composition, and fitness in children. Pediatr Res. 2003; 53:148-52.
39. Chu NF, Rimm EB, Wang DJ, Liou HS, Shieh SM. Clustering of cardiovascular disease risk factors among obese schoolchildren: the Taipei Children Heart Study. Am J Clin Nun: 1998:67:1141-6.
40. Chu NF, Wang DJ, Shieh SM, Rimm EB. Plasma leptin concentrations and obesity in relation to insulin resistance syndrome components among school children in Taiwan: The Taipei Children Heart Study. Im J Obes. 2000:24:1265-71.
41. Ma Z, Gingerich RL, Santiago JV, Klein S, Smith CH, Landt M. Radioimmunoassay of leptin in human plasma. Clin Client. 1996:42:942-6.
42. Jiang X, Srinivasan SR, Berenson GS. Relation of obesity to insulin secretion and clearance in adolescents: The Bogalusa Heart Study. Int J Obes. 1996:20:951-6.
43. Duncan MH, Singh BM, Wise PH, Carter G. A simple measure of insulin resistance. Lancet. 1995;346:120-1.
44. White H. Maximum likelihood estimation of misspecified models. Econometrica. 1982:50:1-2.
45. Matsubara M, Maruoka S, Katayose S. Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Euro J Endocrinol. 2002;147: 173-80.
46. Asayama K, Hayashibe H, Dobshi K, et al. Decrease in serum adiponectin level due to obesity and visceral fat accumulation in children. Obes Res. 2003:11:1072-9.
47. Berg AH, Combs TP, Scherer PE. ACRP 30/adiponectin: an adipocytokine regulating glucose and lipid metabolism. Trends Endocrinol Metab. 2002;13:84-9.
48. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectin in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 2001:86:1930-5.
49. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetes patients. Arterioseler Thromb Vase Biol. 2000;20: 1595-9.
50. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 2002:8; 1288-95.
51. Leibowitz SF, Wortley KE. Hypothalamic control of energy balance; different peptides, different functions. Peptides. 2004;25:473-504.
52. Sahu A. Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology. 2004;145: 2613-20.
53. Qi Y, Takahashi N, Hileman SM, et al. Adiponectin acts in the brain to decrease body weight. Nat Med. 2004;10:524-9.